Avid Bioservices, Inc. (CDMO) |
|
15.58 0.13 (0.84%)
|
06-01 16:00 |
|
Open: |
15.45 |
Pre. Close: |
15.45 |
|
High:
|
15.86 |
Low:
|
15.14 |
|
Volume:
|
292,240 |
Market Cap:
|
974(M) |
|
|
|
Technical analysis |
as of: 2023-06-01 4:43:20 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 19.95  One year: 22.02 |
| Support: |
Support1: 14.21 Support2: 11.82 |
| Resistance: |
Resistance1: 17.08 Resistance2: 18.86 |
| Pivot: |
15.95 |
| Moving Average: |
MA(5): 15.27  MA(20): 16.53
MA(100): 17.09 MA(250): 16.64 |
| MACD: |
MACD(12,26): -0.9 Signal(9): -0.8 |
| Stochastic oscillator: |
%K(14,3): 25.6 %D(3): 22.3 |
| RSI: |
RSI(14): 39.6 |
| 52-week: |
High: 21.04 Low: 11.34 |
| Average Vol(K): |
3-Month: 606 (K) 10-Days: 554 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CDMO ] has closed above bottom band by 42.1%. Bollinger Bands are 46.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
15.87 - 15.94 |
15.94 - 16.01 |
|
Low:
|
14.98 - 15.04 |
15.04 - 15.12 |
|
Close:
|
15.46 - 15.56 |
15.56 - 15.68 |
|
Company Description |
|
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. |
Headline News |
Thu, 01 Jun 2023
A Look at Avid Bioservices Inc. (CDMO) Shares in the Recent Past ... - SETE News
Wed, 31 May 2023
Principal Financial Group Inc. Increases Holdings in Avid ... - Best Stocks
Wed, 31 May 2023
Principal Financial Group Inc. Raises Holdings in Avid Bioservices ... - MarketBeat
Tue, 30 May 2023
Viral Vector Manufacturing Global Market is Predicted to Exhibit ... - GlobeNewswire
Sun, 21 May 2023
Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding - Simply Wall St
Thu, 11 May 2023
Laughing Water Capital Q1 2023 Letter - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
63 (M) |
| Shares Float |
58 (M) |
|
% Held by Insiders
|
0.6 (%) |
|
% Held by Institutions
|
109.1 (%) |
|
Shares Short
|
5,260 (K) |
|
Shares Short P.Month
|
4,990 (K) |
Stock Financials |
|
EPS
|
1.67 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.96 |
|
Profit Margin (%)
|
82.7 |
|
Operating Margin (%)
|
2.7 |
|
Return on Assets (ttm)
|
0.6 |
|
Return on Equity (ttm)
|
96.2 |
|
Qtrly Rev. Growth
|
20.7 |
|
Gross Profit (p.s.)
|
0.58 |
|
Sales Per Share
|
2.24 |
|
EBITDA (p.s.)
|
0.16 |
|
Qtrly Earnings Growth
|
-79.7 |
|
Operating Cash Flow
|
-15 (M) |
|
Levered Free Cash Flow
|
-68 (M) |
Stock Valuations |
|
PE Ratio
|
9.27 |
|
PEG Ratio
|
97.2 |
|
Price to Book value
|
5.26 |
|
Price to Sales
|
6.92 |
|
Price to Cash Flow
|
-64.67 |
Stock Dividends |
|
Dividend
|
0.66 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
4.2% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
